GlassScriptPhysician profile
Neeta Hasmukh
NPI 1922431188
$6,445.39
in general payments reported to CMS, 2019-2025
27 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 91% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $347 · 2021: $1,543 · 2022: $531 · 2023: $159 · 2024: $504 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,536 · Food and Beverage: $1,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,535.80 |
| Food and Beverage | $1,259.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $1,625.46 | 2024-2025 | |
| Paragon 28, INC. | $1,140.79 | 2021-2022 | |
| Medinc of Texas | $1,101.00 | 2019 | |
| Stryker Corporation | $628.19 | 2021-2025 | Asnis, N/A, Anchorage |
| Bard Peripheral Vascular, INC. | $331.44 | 2019-2020 | |
| Smith+Nephew, INC. | $265.84 | 2019-2024 | Collagenase Santyl, Regranex |
| Medtronic, INC. | $213.50 | 2024-2025 | Intellis Adaptivestim, Vanta Adaptivestim |
| Organogenesis INC. | $169.22 | 2022-2025 | Puraply Wound Matrix |
| Triad Life Sciences INC. | $155.83 | 2022 | |
| Kerecis Limited | $117.78 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $98.68 | 2024-2025 | |
| Mission Medical Distribution, LLC | $90.95 | 2023-2024 | |
| Integra Lifesciences Corporation | $78.11 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $61.84 | 2021 | |
| Paratek Pharmaceuticals, INC. | $47.70 | 2025 | Nuzyra |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $44.51 | 2022-2023 | |
| Acera Surgical, INC. | $39.42 | 2021 | |
| Amgen INC. | $34.74 | 2024 | Krystexxa |
| Depuy Synthes Sales INC. | $32.90 | 2022 | |
| Nvision Biomedical Technologies, INC. | $28.92 | 2023 | Foot and Ankle |
| Mimedx Group, INC. | $28.43 | 2025 | |
| Abbvie INC. | $24.74 | 2025 | |
| Averitas Pharma INC. | $22.01 | 2024 | Qutenza |
| Tactile Systems Technology INC | $19.92 | 2021 | |
| Davol INC. | $19.70 | 2022 | |
| Orthofix Medical, INC. | $12.20 | 2019 | |
| Djo, LLC | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeta Hasmukh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.